Pascale Boissel
Vermögen: 1 852 $ am 30.06.2026
Vermögen: 1 852 $ am 30.06.2026
Ms. Pascale Boissel is an Independent Member-Supervisory Board at Innate Pharma SA and an Independent Non-Executive Director at Sartorius Stedim Biotech SA. She is on the Board of Directors at Innate Pharma SA and Sartorius Stedim Biotech SA. Ms. Boissel was previously employed as a CFO, Director-Finance & Administration by ENYO Pharma SA, a Chief Financial Officer by Novadiscovery SA, an Independent Director by Poxel SA, a Director-Finance & Administration & Deputy CEO by BioAster, and a Chief Financial Officer & Head-Media Relations by Ipsogen SA. She received her undergraduate degree from École des Hautes Études Commerciales de Paris and an MBA from École des Hautes Études Commerciales de Paris.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.03.2026 | 1.000 ( 0 % ) | 1 852 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SARTORIUS STEDIM BIOTECH | Direktor/Vorstandsmitglied | 26.03.2019 |
| INNATE PHARMA | Direktor/Vorstandsmitglied | 19.05.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company | Finanzdirektor/CFO | 01.01.2021 |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Finanzdirektor/CFO | 01.05.2018 |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services Operates as a research institute | Finanzdirektor/CFO | 01.12.2016 |
| QIAGEN MARSEILLE | Finanzdirektor/CFO | 01.01.2012 |
| POXEL | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Poxel SA
Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
École des Hautes Études Commerciales de Paris
École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA Medical SpecialtiesHealth Technology Manufactures and supplies biopharmaceutical products and medical equipment | Health Technology |
QIAGEN Marseille SA
QIAGEN Marseille SA Miscellaneous Commercial ServicesCommercial Services Develops and markets molecular diagnostic tests for cancer | Commercial Services |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services Operates as a research institute | Commercial Services |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen